Creating immune privilege: Active local suppression that benefits friends, but protects foes

Andrew L. Mellor, David H. Munn

Research output: Contribution to journalComment/debate

227 Citations (Scopus)

Abstract

Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.

Original languageEnglish (US)
Pages (from-to)74-80
Number of pages7
JournalNature Reviews Immunology
Volume8
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Immunotherapy
Neoplasms
Chronic Disease
Antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Creating immune privilege : Active local suppression that benefits friends, but protects foes. / Mellor, Andrew L.; Munn, David H.

In: Nature Reviews Immunology, Vol. 8, No. 1, 01.01.2008, p. 74-80.

Research output: Contribution to journalComment/debate

@article{cb09c760dc554b09a3ab498d423595aa,
title = "Creating immune privilege: Active local suppression that benefits friends, but protects foes",
abstract = "Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.",
author = "Mellor, {Andrew L.} and Munn, {David H.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1038/nri2233",
language = "English (US)",
volume = "8",
pages = "74--80",
journal = "Nature Reviews Immunology",
issn = "1474-1733",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Creating immune privilege

T2 - Active local suppression that benefits friends, but protects foes

AU - Mellor, Andrew L.

AU - Munn, David H.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.

AB - Natural regulatory mechanisms prevent inappropriate immune activation to self and innocuous foreign antigens. Here, we adapt the notion of immune privilege, which was originally applied to transplanted tissues, to consider how antigenic tumour cells and chronic pathogens might exploit natural regulatory mechanisms to become non-immunogenic. This conceptual approach reveals new mechanistic perspectives that may help to explain the paradoxical persistence of tumours and chronic pathogens, and suggests new opportunities to improve immunotherapy to treat these chronic inflammatory diseases.

UR - http://www.scopus.com/inward/record.url?scp=37549061827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549061827&partnerID=8YFLogxK

U2 - 10.1038/nri2233

DO - 10.1038/nri2233

M3 - Comment/debate

C2 - 18064049

AN - SCOPUS:37549061827

VL - 8

SP - 74

EP - 80

JO - Nature Reviews Immunology

JF - Nature Reviews Immunology

SN - 1474-1733

IS - 1

ER -